1.Setting time of root canal sealers and root-end filling materials by different measuring methods
Gyu-Yeon SHIM ; Seong-jin SHIN ; Seunghan OH ; Ji-Myung BAE
Korean Journal of Dental Materials 2023;50(3):169-178
The aim of this study was to evaluate the differences in setting times based on the methods for dental root canal sealers and calcium silicate cement used in root-end filling. Five kinds of dental root canal sealers and four kinds of calcium silicate cement for root-end filling were selected for the experiments. All materials were mixed according to the manufacturers’ instructions and stored at 37 ℃ with a relative humidity of 95%. Setting time was measured using a 1/4 pound Gillmore needle and a 1 pound Gillmore needle to determine the time until indentation was no longer visible or the time until 2 mm penetration was no longer possible. The determination of indentation was based on the absence of visible impressions on the material surface when Gillmore needle was placed vertically. When comparing indentation time and penetration time using same type of Gillmore needle, only ProRoot MTA using 1 pound Gillmore needle showed significant difference between measuring methods (P<0.05) while there are no differences in measuring methods in other materials (P>0.05). By this study, we could expect to measure a setting time relatively similar to real clinical conditions through indentation method.
2.Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Hyaluronidase in Preventing Perineal Trauma in Nulliparous Women
Hayan KWON ; Hyun Soo PARK ; Jae Yoon SHIM ; Kyo Won LEE ; Suk Joo CHOI ; Gyu Yeon CHOI
Yonsei Medical Journal 2020;61(1):79-84
Edema
;
Episiotomy
;
Female
;
Humans
;
Hyaluronoglucosaminidase
;
Incidence
;
Lacerations
;
Parity
;
Wounds and Injuries
3.Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score.
Sang Cheol BAE ; Jin Hye CHA ; Jung Yoon CHOE ; Sung Jae CHOI ; Soo Kyung CHO ; Won Tae CHUNG ; Chung Il JOUNG ; Young Ok JUNG ; Young Mo KANG ; Dong Wook KIM ; Jinseok KIM ; Young Joo KIM ; Choong Ki LEE ; Hye Soon LEE ; Jisoo LEE ; Sang Heon LEE ; Sang Hoon LEE ; Shin Seok LEE ; Yeon Ah LEE ; Seong Su NAH ; Seung Cheol SHIM ; Gwan Gyu SONG ; Chang Hee SUH ; Soyoung WON ; Wan Hee YOO ; Bo Young YOON
Journal of Rheumatic Diseases 2018;25(2):122-130
OBJECTIVE: Productivity loss was compared by 3-stage of disease activity and associations between higher disease activity and high productivity loss were identified. METHODS: Data were extracted from Rheumatoid Arthritis (RA) Patient-reported Outcomes Research, which enrolled 2,000 RA patients (>20-year) on disease-modifying-antirheumatic-drugs (DMARDs) (≥6-month) from December 2012 to June 2013. This included 1,457 RA patients with the disease activity score (DAS-28-ESR) in their medical charts. Productivity loss in time and indirect cost was estimated using The World Health Organization Health and Work Performance Questionnaire (HPQ). Baseline characteristics and productivity loss outcomes were compared according to DAS-28-ESR groups. RESULTS: 84.4% were females, 54.2% had low DAS-28-ESR ( < 3.2), and 38.2% and 7.6% had moderate (3.2∼5.1) and high DAS-28-ESR (>5.1). Patients with moderate to high DAS-28-ESR had higher lost productivity time (LPT) and monthly costs of LPT than those with low DAS-28-ESR (time in hours: 110.0±58.4 vs. 132.4±57.2 vs. 71.5±52.0, p < 0.0001; monthly costs of LPT in 1,000 Korean won: 1,097±607 vs. 1,302±554 vs. 741±531, p < 0.0001). Multiple regression analyses revealed significant associations with high LPT in high (adjusted odds ratio [OR]=3.87, 95% confidence interval [CI]: 2.18∼6.87) and moderate DAS-28-ESR (adjusted OR=1.88, 95% CI: 1.41∼2.52) compared to low DAS-28-ESR. In addition, positive associations with high monthly costs of LPT were observed in high (adjusted OR=3.45, 95% CI: 1.98∼5.99) and moderate DAS-28-ESR (adjusted OR=1.93, 95% CI: 1.43∼2.54) compared to low DAS-28-ESR. CONCLUSION: Timely therapeutic strategies should be taken into consideration given that the RA patients with moderate to high DAS-28-ESR showed strong associations with high productivity loss for effective management of RA.
Arthritis, Rheumatoid*
;
Efficiency*
;
Female
;
Humans
;
Odds Ratio
;
Outcome Assessment (Health Care)
;
Work Performance
;
World Health Organization
4.A Systematic Review of Benefit of Silicone Intubation in Endoscopic Dacryocystorhinostomy.
Min Gyu KANG ; Woo Sub SHIM ; Dong Keun SHIN ; Joo Yeon KIM ; Ji Eun LEE ; Hahn Jin JUNG
Clinical and Experimental Otorhinolaryngology 2018;11(2):81-88
OBJECTIVES: Insertion of a silicone stent during endoscopic dacryocystorhinostomy (DCR) is the most common procedure to prevent rhinostomy closure. It has been claimed that silicone intubation improves the surgical outcomes of endoscopic DCR. However, many reports have documented an equally high success rate for surgery without silicone intubation. Accordingly, we conducted a systematic review and meta-analysis to clarify the outcomes of endoscopic DCR with and without silicone intubation and determine whether silicone intubation is actually beneficial for patients. METHODS: PubMed, Embase, and Cochrane Library databases were searched to identify relevant controlled trials evaluating endoscopic DCR with and without silicone intubation. The search was restricted to English articles published between January 2007 and December 2016. Relevant articles were reviewed to obtain information pertaining to interventions and outcomes. We also performed a meta-analysis of the relevant literature. RESULTS: In total, 1,216 patients included in 12 randomized controlled trials were pooled. A total of 1,239 endoscopic DCR procedures were performed, and silicone stents were used in 533 procedures. The overall success rate for endoscopic DCR was 91.9% (1,139/1,239), while the success rates with and without silicone intubation were 92.9% (495/533) and 91.2% (644/706), respectively. There was no statistically significant heterogeneity among the included studies. A meta-analysis using a fixed-effects models showed no significant difference in the success rate between endoscopic DCR with silicone intubation and that without silicone intubation (OR, 1.38; 95% CI, 0.89 to 2.12; P=0.148; z=1.45). Furthermore, there were no significant differences with regard to surgical complications such as synechia, granulation, and postoperative bleeding. CONCLUSION: The findings of our meta-analysis suggest that the success rate and postoperative complication rate for endoscopic DCR is not influenced by the use of silicone intubation during the procedure.
Dacryocystorhinostomy*
;
Endoscopy
;
Hemorrhage
;
Humans
;
Intubation*
;
Population Characteristics
;
Postoperative Complications
;
Silicon*
;
Silicones*
;
Stents
5.Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction.
Yong Hoon KIM ; Ae Young HER ; Seung Woon RHA ; Byoung Geol CHOI ; Minsuk SHIM ; Se Yeon CHOI ; Jae Kyeong BYUN ; Hu LI ; Woohyeun KIM ; Jun Hyuk KANG ; Jah Yeon CHOI ; Eun Jin PARK ; Sung Hun PARK ; Sunki LEE ; Jin Oh NA ; Cheol Ung CHOI ; Hong Euy LIM ; Eung Ju KIM ; Chang Gyu PARK ; Hong Seog SEO ; Dong Joo OH
Yonsei Medical Journal 2017;58(4):720-730
PURPOSE: Differences in the utility of routine angiographic follow-up (RAF) and clinical follow-up (CF) after percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) are not well understood. The present study aimed to compare the 3-year clinical outcomes of RAF and CF in AMI patients who underwent PCI with drug-eluting stents (DES). MATERIALS AND METHODS: A total of 774 consecutive AMI patients who underwent PCI with DES were enrolled. RAF was performed at 6 to 9 months after index PCI (n=425). The remaining patients were medically managed and clinically followed (n=349); symptom-driven events were captured. To adjust for any potential confounders, a propensity score matched analysis was performed using a logistic regression model, and two propensity-matched groups (248 pairs, n=496, C-statistic=0.739) were generated. Cumulative clinical outcomes up to 3 years were compared between RAF and CF groups. RESULTS: During the 3-year follow-up period, the cumulative incidences of revascularization [target lesion revascularization: hazard ratio (HR), 2.40; 95% confidence interval (CI), 1.18–4.85; p=0.015, target vessel revascularization (TVR): HR, 3.33; 95% CI, 1.69–6.58; p=0.001, non-TVR: HR, 5.64; 95% CI, 1.90–16.6; p=0.002] and major adverse cardiac events (MACE; HR, 3.32; 95% CI, 1.92–5.73; p<0.001) were significantly higher in the RAF group than the CF group. However, the 3-year incidences of death and myocardial infarction were not different between the two groups. CONCLUSION: RAF following index PCI with DES in AMI patients was associated with increased incidences of revascularization and MACE. Therefore, CF seems warranted for asymptomatic patients after PCI for AMI.
Coronary Angiography
;
Drug-Eluting Stents
;
Follow-Up Studies*
;
Humans
;
Incidence
;
Logistic Models
;
Myocardial Infarction*
;
Percutaneous Coronary Intervention*
;
Propensity Score
6.Anti-apoptotic and myocardial protective effects of ethyl pyruvate after regional ischaemia/reperfusion myocardial damage in an in vivo rat model.
Haeng Seon SHIM ; Wang Gyu LEE ; Yeon A KIM ; Jeong Yeol HAN ; Miyeong PARK ; Yun Gyu SONG ; Joon Soo KIM ; Il-Woo SHIN
Singapore medical journal 2017;58(9):557-561
INTRODUCTIONThe integration of reactive oxygen species is strongly associated with important pathophysiological mechanisms that mediate myocardial ischaemia/reperfusion (I/R) damage. Pyruvate is an efficacious scavenger of reactive oxygen species and a previous study has shown that ethyl pyruvate (EP) has a myocardial protective effect against regional I/R damage in an in vivo rat model. The purpose of this study was to determine whether the myocardial protective effect of EP is associated with anti-apoptosis.
METHODSRats were allocated to receive EP dissolved in lactated Ringer's solution or lactated Ringer's solution alone, via intraperitoneal infusion one hour before ischaemia. They were exposed to 30 minutes of ischaemia followed by reperfusion of the left coronary artery territory over two hours. Anti-apoptotic effects were checked using several biochemical parameters after two hours of reperfusion. Apoptosis was analysed using measured caspase-3 activity, Western blotting of B-cell lymphoma 2 (Bcl-2) family protein cleaved by caspase-3, and assessment of DNA laddering patterns and the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining test.
RESULTSIn ischaemic myocardium, EP increased Bcl-2 expression, but reduced Bcl-2-associated X protein and cleaved caspase-3 expressions. EP reduced the expression of DNA laddering and the number of myocardial I/R-damaged TUNEL-positive cells.
CONCLUSIONThis study demonstrated that EP has an anti-apoptotic effect after regional I/R damage in an in vivo rat heart model. The myocardial protective effect of EP may be related to its anti-apoptotic effect.
7.Impact of Cigarette Smoking: a 3-Year Clinical Outcome of Vasospastic Angina Patients.
Byoung Geol CHOI ; Seung Woon RHA ; Taeshik PARK ; Se Yeon CHOI ; Jae Kyeong BYUN ; Min Suk SHIM ; Shaopeng XU ; Hu LI ; Sang Ho PARK ; Ji Young PARK ; Woong Gil CHOI ; Yun Hyeong CHO ; Sunki LEE ; Jin Oh NA ; Cheol Ung CHOI ; Hong Euy LIM ; Jin Won KIM ; Eung Ju KIM ; Chang Gyu PARK ; Hong Seog SEO ; Dong Joo OH
Korean Circulation Journal 2016;46(5):632-638
BACKGROUND AND OBJECTIVES: Cigarette smoking is a risk significant factor in coronary artery disease (CAD) and vasospastic angina (VSA). However, it is largely unknown whether smoking adds to any long-term clinical risk in VSA patients. SUBJECTS AND METHODS: A total of 2797 patients without significant CAD underwent acetylcholine (Ach) provocation test between November 2004 and October 2010. Patients were divided into three groups, based on the presence of coronary artery spasm (CAS) and smoking habits (non-CAS group: n=1188, non-smoking CAS group: n=1214, smoking CAS group: n=395). All CAS patients were prescribed with anti-anginal medications for at least 6 months. The incidence of major clinical outcomes and recurrent angina of these groups were compared up to 3 years. RESULTS: There were considerable differences in the baseline clinical and angiographic characteristics among the three groups, but there was no difference in the endpoints among the three groups (including individual and composite hard endpoints) such as death, myocardial infarction, de novo percutaneous coronary intervention, cerebrovascular accident, and major adverse cardiac events. However, there was a higher incidence of recurrent angina in both the non-smoking CAS group and smoking CAS group, as compared to the non-CAS group. In multivariable adjusted Cox-proportional hazards regression analysis, smoking CAS group exhibited a higher incidence of recurrent angina compared with the non-CAS group (hazard ratio [HR]; 2.46, 95% confidence interval [CI]; 1.46-4.14, p=0.001) and non-smoking CAS group (HR; 1.76, 95% CI; 1.08-2.87, p=0.021). CONCLUSION: Cigarette smoking CAS group exhibited higher incidence of recurrent angina during the 3-year clinical follow-up compared with both the non-CAS group and non-smoking CAS group. Quitting of smoking, paired with intensive medical therapy and close clinical follow-up, can help to prevent recurrent angina.
Acetylcholine
;
Coronary Artery Disease
;
Coronary Vessels
;
Follow-Up Studies
;
Humans
;
Incidence
;
Myocardial Infarction
;
Percutaneous Coronary Intervention
;
Smoke
;
Smoking*
;
Spasm
;
Stroke
;
Tobacco Products*
8.Indications for Detection, Completion, and Retention Rates of Small Bowel Capsule Endoscopy Based on the 10-Year Data from the Korean Capsule Endoscopy Registry.
Yun Jeong LIM ; Oh Young LEE ; Yoon Tae JEEN ; Chi Yeon LIM ; Dae Young CHEUNG ; Jae Hee CHEON ; Byong Duk YE ; Hyun Joo SONG ; Jin Su KIM ; Jae Hyuk DO ; Kwang Jae LEE ; Ki Nam SHIM ; Dong Kyung CHANG ; Cheol Hee PARK ; Byung Ik JANG ; Jeong Seop MOON ; Hoon Jai CHUN ; Myung Gyu CHOI ; Jin Oh KIM
Clinical Endoscopy 2015;48(5):399-404
BACKGROUND/AIMS: Capsule endoscopy (CE) is widely used. However, CE has limitations including incomplete examination, inadequate bowel preparation, and retention. The aim of this study was to estimate the indications for and detection, completion, and retention rates of small intestine CE based on the 10-year data from the Korean Capsule Endoscopy Registry. METHODS: Twenty-four hospitals participated in this study. Clinical information, such as reasons for CE, method and quality of bowel preparation, and incomplete examination and capsule retention rates, was collected and analyzed. RESULTS: A total of 2,914 CEs were registered. The most common reason for CE was obscure gastrointestinal bleeding (59%). Significant lesions were detected in 66% of cases. Positive CE diagnosis occurred in 63% of cases. The preparation method did not significantly affect the quality of bowel preparation for CE. The overall incomplete rate was 33%, and was high in the elderly and those with poor bowel preparation. Capsule retention was 3% and high in patients with small bowel tumors and Crohn's disease and in children under 10 years of age. CONCLUSIONS: CE is a valuable technique; while the overall detection rate is high, incompletion and retention rates are also relatively high. CE should be carefully considered in the elderly and children less than 10 years of age, as well as in patients with small bowel tumors and Crohn's disease.
Aged
;
Capsule Endoscopy*
;
Child
;
Crohn Disease
;
Diagnosis
;
Hemorrhage
;
Humans
;
Intestine, Small
9.Practice patterns in the management of threatened preterm labor in Korea: A multicenter retrospective study.
Han Sung HWANG ; Sung Hun NA ; Sung Eun HUR ; Soon Ae LEE ; Kyung A LEE ; Geum Joon CHO ; Kwan Young OH ; Chan Hee JIN ; Seung Mi LEE ; Jae Eun SHIN ; Kyo Hoon PARK ; Ji Young LIM ; Suk Joo CHOI ; Joon Ho LEE ; Sae Kyung CHOI ; Jae Yoon SHIM ; Yun Sung JO ; Gyu Yeon CHOI ; Young Han KIM ; Ki Cheol KIL ; Jong Woon KIM ; Dong Wook KWAK ; Yun Dan KANG ; Young Ju KIM
Obstetrics & Gynecology Science 2015;58(3):203-209
OBJECTIVE: This study aimed to examine clinical practice patterns in the management of pregnant women admitted with threatened preterm labor (TPL) in Korea. METHODS: Data from women admitted with a diagnosis of TPL were collected from 22 hospitals. TPL was defined as regular uterine contractions with or without other symptoms such as pelvic pressure, backache, increased vaginal discharge, menstrual-like cramps, bleeding/show and cervical changes. Data on general patient information, clinical characteristics at admission, use of tocolytics, antibiotics, and corticosteroids, and pregnancy outcomes were collected using an online data collections system. RESULTS: A total of 947 women with TPL were enrolled. First-line tocolysis was administered to 822 (86.8%) patients. As a first-line tocolysis, beta-agonists were used most frequently (510/822, 62.0%), followed by magnesium sulfate (183/822, 22.3%), calcium channel blockers (91/822, 11.1%), and atosiban (38/822, 4.6%). Of the 822 women with first-line tocolysis, second-line tocolysis were required in 364 (44.3%). Of 364 with second-line, 199 had third-line tocolysis (37.4%). Antibiotics were administered to 29.9% of patients (284/947) with single (215, 22.7%), dual (26, 2.7%), and triple combinations (43, 4.5%). Corticosteroids were administered to 420 (44.4%) patients. Betamethasone was administered to 298 patients (71.0%), and dexamethasone was administered to 122 patients (29.0%). CONCLUSION: Practice patterns in the management of TPL in Korea were quite various. It is needed to develop standardized practice guidelines for TPL management.
Adrenal Cortex Hormones
;
Anti-Bacterial Agents
;
Back Pain
;
Betamethasone
;
Calcium Channel Blockers
;
Dexamethasone
;
Diagnosis
;
Female
;
Humans
;
Korea
;
Magnesium Sulfate
;
Muscle Cramp
;
Obstetric Labor, Premature*
;
Physician's Practice Patterns
;
Pregnancy
;
Pregnancy Outcome
;
Pregnant Women
;
Premature Birth
;
Retrospective Studies*
;
Tocolysis
;
Tocolytic Agents
;
Uterine Contraction
;
Vaginal Discharge
10.A Case of Segniliparus rugosus Pulmonary Infection in an Immunocompetent Patient with Non-cystic Fibrosis.
Jung Yeon LEE ; Gyu Rak CHON ; Tae Young JUNG ; Heungsup SUNG ; Tae Sun SHIM ; Kyung Wook JO
Tuberculosis and Respiratory Diseases 2014;77(5):227-229
Segniliparus species is a novel genus that is reported to be the new emerging respiratory pathogens. Here, we report a very rare case of S. rugosus pulmonary infection in an immunocompetent patient with non-cystic fibrosis. The organism was identified by 16S rRNA gene sequencing. The patient was successfully treated with antibiotics.
Anti-Bacterial Agents
;
Fibrosis*
;
Genes, rRNA
;
Humans
;
Nontuberculous Mycobacteria
;
Respiratory Tract Infections
;
Sequence Analysis, RNA

Result Analysis
Print
Save
E-mail